These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Diagnosis
71 results:

  • 1. Shared Decision-Making in colorectal cancer Screening for Older Adults: A Secondary Analysis of a Cluster Randomized Clinical Trial.
    Sepucha KR; Chang Y; Valentine KD; Atlas SJ; Han PKJ; Leavitt LJ; Mancini B; Richter JM; Siegel LC; Fairfield KM; Simmons LH
    JAMA Netw Open; 2024 Aug; 7(8):e2429645. PubMed ID: 39178001
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identifying risk factors for anal cancer in people with HIV in Spain: a multicentre retrospective cohort study nested in the PISCIS cohort.
    Llibre JM; Revollo B; Aceiton J; Díaz Y; Domingo P; Burgos J; Sorni P; Saumoy M; Knobel H; Navarro M; Leon E; Orti A; Arbonés L; Mera A; Deig E; Sirera G; Miró JM; Casabona J; Martin-Iguacel R;
    Lancet HIV; 2024 Sep; 11(9):e598-e606. PubMed ID: 39102835
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants.
    Chen S; Gu J; Wu K; Zhao X; Lu Y
    Cancer Biol Med; 2024 Jun; 21(6):473-83. PubMed ID: 38940668
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.
    Simoni O; Scarpa M; Castagliuolo I; Stepanyan A; Angriman I; Kotsafti A; Nacci C; Scognamiglio F; Negro S; D'Angelo A; Chiminazzo V; Businello G; Ruffolo C; Salmaso R; Franzato B; Gruppo M; Pilati P; Scapinello A; Pozza A; Stecca T; Massani M; Cataldo I; Brignola S; Dei Tos AP; Ceccon C; Guzzardo V; Vignotto C; Facci L; Maretto I; Agostini M; Marchegiani F; Becherucci G; Zizzo M; Bordignon G; Merenda R; Pirozzolo G; Recordare A; Pozza G; Godina M; Mondi I; Verdi D; Lio CD; Laurino L; Saadeh L; Rivella G; Guerriero S; Romiti C; Portale G; Cipollari C; Spolverato YC; Noaro G; Cola R; Candioli S; Gavagna L; Ricagna F; Ortenzi M; Guerrieri M; Tagliente G; Tomassi M; Tedeschi U; Salmaso B; Buzzi G; Parini D; Prando D; Zuin M; Bergamo F; Zagonel V; Porzionato A; Cavallin F; Camillo BD; Cristoforo LD; Bao QR; Pucciarelli S; Bardini R; Spolverato G; Fassan M; Scarpa M;
    Cancer; 2024 Jul; 130(13):2272-2286. PubMed ID: 38644692
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Application research of radiomics in colorectal cancer: A bibliometric study.
    Yang L; Wang B; Shi X; Li B; Xie J; Wang C
    Medicine (Baltimore); 2024 Apr; 103(15):e37827. PubMed ID: 38608072
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Autonomous Artificial Intelligence vs Artificial Intelligence-Assisted Human Optical diagnosis of colorectal Polyps: A Randomized Controlled Trial.
    Djinbachian R; Haumesser C; Taghiakbari M; Pohl H; Barkun A; Sidani S; Liu Chen Kiow J; Panzini B; Bouchard S; Deslandres E; Alj A; von Renteln D
    Gastroenterology; 2024 Jul; 167(2):392-399.e2. PubMed ID: 38331204
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Demographic and clinico-pathological characteristics of colorectal cancer in Kirkuk governorate, Iraq.
    Arif KB; Said S; Khiro N; Ibrahem S; Al-Ghamdi S
    Hum Antibodies; 2023; 31(4):89-98. PubMed ID: 38217589
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development and validation of epigenetic modification-related signals for the diagnosis and prognosis of colorectal cancer.
    Li X; Li J; Li J; Liu N; Zhuang L
    BMC Genomics; 2024 Jan; 25(1):51. PubMed ID: 38212708
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance.
    Pereira PL; Siemou P; Rempp HJ; Hoffmann R; Hoffmann RT; Kettenbach J; Clasen S; Helmberger T
    Eur Radiol; 2024 Jul; 34(7):4663-4671. PubMed ID: 38041717
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association of ICD-10 Clinical Modification Codes for Social Determinants of Health with Surgical Outcomes and Hospital Charges Among cancer Patients.
    Diaz A; Pawlik T
    Ann Surg Oncol; 2024 Feb; 31(2):1171-1177. PubMed ID: 38006529
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Disparities among Black and Hispanic colorectal cancer patients: Findings from the California cancer Registry.
    Mendez JS; Wang R; Liu L; Zhang J; Schmit SL; Figueiredo J; Lenz HJ; Stern MC
    Cancer Med; 2023 Nov; 12(22):20976-20988. PubMed ID: 37909220
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Characteristics and outcomes of rectal cancer in patients with inflammatory bowel disease: a single-center experience.
    Emile SH; Horesh N; Garoufalia Z; Rogers P; Gefen R; Dasilva G; Wexner SD
    Updates Surg; 2024 Jan; 76(1):119-126. PubMed ID: 37814150
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Small extrachromosomal circular DNAs as biomarkers for multi-cancer diagnosis and monitoring.
    Luo X; Zhang L; Cui J; An Q; Li H; Zhang Z; Sun G; Huang W; Li Y; Li C; Jia W; Zou L; Zhao G; Xiao F
    Clin Transl Med; 2023 Sep; 13(9):e1393. PubMed ID: 37649244
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Performances of the Idylla GeneFusion Assay: contribution to a rapid diagnosis of targetable gene fusions in tumour samples.
    Guillard M; Caumont C; Marcorelles P; Merlio JP; Cappellen D; Uguen A
    J Clin Pathol; 2024 Jul; 77(8):561-567. PubMed ID: 37185257
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The association of blood ctDNA levels to mutations of marker genes in colorectal cancer.
    Bai F; Du Q; Zou Q; Xu L; Dong W; Lv X; Han X; Zhou H; Zhang C; Lu T
    Cancer Rep (Hoboken); 2023 Apr; 6(4):e1782. PubMed ID: 36746394
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association of Radiation and Procarbazine Dose With Risk of colorectal cancer Among Survivors of Hodgkin Lymphoma.
    Geurts YM; Shakir R; Ntentas G; Roberti S; Aznar MC; John KM; Ramroth J; Janus CPM; Krol ADG; Roesink JM; van der Maazen RWM; Zijlstra JM; Darby SC; Aleman BMP; van Leeuwen FE; Cutter DJ; Schaapveld M
    JAMA Oncol; 2023 Apr; 9(4):481-489. PubMed ID: 36729438
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Use of a Novel Network-Based Linchpin Score to Characterize Accessibility to the Oncology Physician Workforce in the United States.
    Moen EL; Brooks GA; O'Malley AJ; Schaefer A; Carlos HA; Onega T
    JAMA Netw Open; 2022 Dec; 5(12):e2245995. PubMed ID: 36525275
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Faecal immunochemical testing reduces demand and improves yield of Leicester's 2-week pathway for change in bowel habit.
    Khasawneh F; Osborne T; Danaher P; Barnes D; Chapman CJ; Stephenson JA; Singh B
    Colorectal Dis; 2023 Apr; 25(4):640-646. PubMed ID: 36478367
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Serum metabolite signatures in normal individuals and patients with colorectal adenoma or colorectal cancer using UPLC-MS/MS method.
    Guo J; Pan Y; Chen J; Jin P; Tang S; Wang H; Su H; Wang Q; Chen C; Xiong F; Liu K; Li Y; Su M; Tang T; He Y; Sheng J
    J Proteomics; 2023 Jan; 270():104741. PubMed ID: 36174955
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Novel neoplasms associated with syndromic pediatric medulloblastoma: integrated pathway delineation for personalized therapy.
    Georgescu MM; Whipple SG; Notarianni CM
    Cell Commun Signal; 2022 Aug; 20(1):123. PubMed ID: 35978432
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.